On August 7, 2019, Aprogen pharmaceuticals,Inc. (KOSE:A003060) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,010 KRW | 0.00% |
|
-0.49% | -65.17% |
1st Jan change | Capi. | |
---|---|---|
-65.17% | 47.93M | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- A003060 Stock
- News Aprogen Biologics Inc.
- Aprogen pharmaceuticals,Inc. announced that it has received KRW 20.000000214 billion in funding from Aprogen KIC Inc.